NO973338L - N-(4-aryl-tiazol-2-yl)-sulfonamid-derivater og deres anvendelse - Google Patents
N-(4-aryl-tiazol-2-yl)-sulfonamid-derivater og deres anvendelseInfo
- Publication number
- NO973338L NO973338L NO973338A NO973338A NO973338L NO 973338 L NO973338 L NO 973338L NO 973338 A NO973338 A NO 973338A NO 973338 A NO973338 A NO 973338A NO 973338 L NO973338 L NO 973338L
- Authority
- NO
- Norway
- Prior art keywords
- nitro
- lower alkyl
- halogen
- amino
- trifluoromethyl
- Prior art date
Links
- 229940124530 sulfonamide Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- -1 nitro - Chemical class 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 102100037652 Kynurenine 3-monooxygenase Human genes 0.000 abstract 1
- 108010033242 Kynurenine 3-monooxygenase Proteins 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/50—Nitrogen atoms bound to hetero atoms
- C07D277/52—Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Oppfinnelsen vedrører anvendelsen av derivater med den generelle formel hvor R betyr lavere alkyl, fenyl, benzyl, naftyl, pyridyl eller tienyl, eventuelt substituert med en eller flere lavere alkyl-, lavere alkoksy-, lavere alkylkarbonylamino-, halogen-, cykloalkyl-, nitro-, amino-, metylendioksy-, fenoksy- eller benzyloksy- substituenter, og de aromatiske ringer kan i sin tur være substituert med nitro, halogen eller amino; R1- R4 betyr hydrogen, halogen, hydroksy, lavere alkyl, nitro, cyano, amino, lavere alkoksy, benzyloksy, trifluormetyl eller fenyl, eventuelt substituert med en eller flere lavere alkyl-, trifluormetyl-, nitro-, amino- eller hydroksysubstituenter, og hvor R1 og R2 eller R2 og R3 sammen kan danne en benzenring som eventuelt kan være substituert med halogen, trifluor- metyl, nitro, lavere alkyl eller lavere alkoksy; og deres farmasøytisk akseptable salter som kynurenin-3- hydroksylaseinhibitorer ved kontroll eller forebyg- gelse av nevrodegenerative forstyrrelser, nevrolog- iske forstyrrelser som et resultat av en aktivering av immunsystemet, eller psykiatriske sykdommer og henholdsvis for produksjon av tilsvarende medika- menter.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96111661 | 1996-07-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO973338D0 NO973338D0 (no) | 1997-07-18 |
| NO973338L true NO973338L (no) | 1998-01-20 |
Family
ID=8223010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO973338A NO973338L (no) | 1996-07-19 | 1997-07-18 | N-(4-aryl-tiazol-2-yl)-sulfonamid-derivater og deres anvendelse |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5877193A (no) |
| EP (1) | EP0819681A3 (no) |
| JP (1) | JP2991679B2 (no) |
| KR (1) | KR100247672B1 (no) |
| CN (1) | CN1176101A (no) |
| AU (1) | AU725496B2 (no) |
| BR (1) | BR9704023A (no) |
| CA (1) | CA2210613A1 (no) |
| CO (1) | CO4900053A1 (no) |
| CZ (1) | CZ227397A3 (no) |
| HR (1) | HRP970393A2 (no) |
| HU (1) | HUP9701193A3 (no) |
| IL (1) | IL121298A (no) |
| MA (1) | MA24273A1 (no) |
| MX (1) | MX9705385A (no) |
| NO (1) | NO973338L (no) |
| NZ (1) | NZ328331A (no) |
| PE (1) | PE91298A1 (no) |
| PL (1) | PL321203A1 (no) |
| SG (1) | SG91796A1 (no) |
| TR (1) | TR199700653A2 (no) |
| YU (1) | YU30297A (no) |
| ZA (1) | ZA976222B (no) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9725138D0 (en) * | 1997-11-27 | 1998-01-28 | Pharmacia & Upjohn Spa | Thiophenesulfonamide compounds |
| GB9725141D0 (en) * | 1997-11-27 | 1998-01-28 | Pharmacia & Upjohn Spa | Benzenesulfonamide compounds |
| US6211185B1 (en) * | 1999-05-05 | 2001-04-03 | Veterinary Pharmacy Corporation | Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent |
| SE0001899D0 (sv) * | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
| DK1341779T3 (da) * | 2000-12-13 | 2006-10-30 | Wyeth Corp | Heterocyklisk sulfonamid-inhibitorer af beta-amyloidproduktion |
| EA200400707A1 (ru) | 2001-11-22 | 2004-10-28 | Биовитрум Аб | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 |
| US6869970B2 (en) | 2002-02-04 | 2005-03-22 | Novartis Ag | Crystalline salt forms of valsartan |
| FR2849598B1 (fr) * | 2003-01-07 | 2006-09-22 | Merck Sante Sas | Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete, par augmentation du nombre de cellules des ilots de langerhans |
| FR2849599B1 (fr) * | 2003-01-07 | 2006-12-29 | Merck Sante Sas | Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete |
| JPWO2005054216A1 (ja) * | 2003-12-01 | 2007-06-28 | 株式会社リバース・プロテオミクス研究所 | 新規抗癌剤「スルコキシン」 |
| WO2008022281A1 (en) * | 2006-08-16 | 2008-02-21 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Small molecule inhibitors of kynurenine-3-monooxygenase |
| WO2008022286A2 (en) | 2006-08-16 | 2008-02-21 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Small molecule inhibitors of kynurenine-3-monooxygenase |
| JP5795714B2 (ja) * | 2008-01-15 | 2015-10-14 | シガ・テクノロジーズ・インコーポレーテッド | アレナウイルス感染症の治療のための抗ウイルス薬 |
| WO2009124086A2 (en) * | 2008-04-04 | 2009-10-08 | Siga Technologies, Inc. | Antibacterial drug for treatment of staphylococcus aureus and other gram-positive bacterial infections |
| UA103319C2 (en) * | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| CN101602687A (zh) * | 2008-06-13 | 2009-12-16 | 上海特化医药科技有限公司 | 6-硝基苯乙酮类化合物、其制备方法及用途 |
| SG2014012926A (en) * | 2011-08-30 | 2014-06-27 | Chdi Foundation Inc | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| CN102627589A (zh) * | 2012-04-05 | 2012-08-08 | 天津理工大学 | 一种两步合成制备4-异丙基苯磺酰氯的方法和工艺 |
| CN102633687B (zh) * | 2012-04-05 | 2016-06-08 | 天津瑞岭化工有限公司 | 一种对位取代烷基苯磺酰氯的制备方法和工艺 |
| CN102633696A (zh) * | 2012-04-05 | 2012-08-15 | 天津理工大学 | 一种两步合成制备对位取代烷基苯磺酰氯的方法和工艺 |
| CN102633695A (zh) * | 2012-04-05 | 2012-08-15 | 天津理工大学 | 一种4-异丙基苯磺酰氯的制备方法和工艺 |
| EP3345596B1 (en) * | 2012-09-21 | 2021-01-20 | Rhode Island Hospital | Inhibitors of beta-hydrolase for treatment of cancer |
| WO2017201468A1 (en) | 2016-05-20 | 2017-11-23 | Xenon Pharmaceuticals Inc. | Benzenesulfonamide compounds and their use as therapeutic agents |
| EP3551626B1 (en) | 2016-12-09 | 2023-10-25 | Xenon Pharmaceuticals Inc. | Benzenesulfonamide compounds and their use as therapeutic agents |
| AU2019285184B2 (en) | 2018-06-13 | 2023-11-16 | Xenon Pharmaceuticals Inc. | Benzenesulfonamide compounds and their use as therapeutic agents |
| US10981905B2 (en) | 2018-08-31 | 2021-04-20 | Xenon Pharmaceuticals Inc. | Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents |
| MA53488A (fr) | 2018-08-31 | 2021-12-08 | Xenon Pharmaceuticals Inc | Composés de sulfonamide substitués par hétéroaryle et leur utilisation en tant qu'inhibiteurs de canaux sodiques |
| EP3846793B1 (en) * | 2018-09-07 | 2024-01-24 | PIC Therapeutics, Inc. | Eif4e inhibitors and uses thereof |
| CN114516807B (zh) * | 2022-02-24 | 2023-11-17 | 南京大学 | 一种含硝基多取代芳香二胺单体及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5591761A (en) * | 1993-05-20 | 1997-01-07 | Texas Biotechnology Corporation | Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| NZ247440A (en) * | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
| EP0790057B1 (en) * | 1994-11-29 | 2002-06-05 | Hisamitsu Pharmaceutical Co., Inc. | Antibacterial or bactericide comprising 2-aminothiazole derivative and salts thereof |
| GB9702194D0 (en) * | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
-
1997
- 1997-06-12 US US08/874,050 patent/US5877193A/en not_active Expired - Fee Related
- 1997-07-09 SG SG9702412A patent/SG91796A1/en unknown
- 1997-07-10 EP EP97111745A patent/EP0819681A3/de not_active Ceased
- 1997-07-11 YU YU30297A patent/YU30297A/sh unknown
- 1997-07-11 PE PE1997000613A patent/PE91298A1/es not_active Application Discontinuation
- 1997-07-14 IL IL12129897A patent/IL121298A/xx not_active IP Right Cessation
- 1997-07-14 ZA ZA9706222A patent/ZA976222B/xx unknown
- 1997-07-14 HU HU9701193A patent/HUP9701193A3/hu unknown
- 1997-07-14 NZ NZ328331A patent/NZ328331A/xx unknown
- 1997-07-16 MX MX9705385A patent/MX9705385A/es not_active Application Discontinuation
- 1997-07-16 CA CA002210613A patent/CA2210613A1/en not_active Abandoned
- 1997-07-16 JP JP9190990A patent/JP2991679B2/ja not_active Expired - Fee Related
- 1997-07-17 CO CO97040540A patent/CO4900053A1/es unknown
- 1997-07-17 CZ CZ972273A patent/CZ227397A3/cs unknown
- 1997-07-17 TR TR97/00653A patent/TR199700653A2/xx unknown
- 1997-07-17 MA MA24722A patent/MA24273A1/fr unknown
- 1997-07-18 NO NO973338A patent/NO973338L/no not_active Application Discontinuation
- 1997-07-18 HR HR96111661.3A patent/HRP970393A2/xx not_active Application Discontinuation
- 1997-07-18 PL PL97321203A patent/PL321203A1/xx unknown
- 1997-07-18 BR BR9704023A patent/BR9704023A/pt active Search and Examination
- 1997-07-18 CN CN97114715A patent/CN1176101A/zh active Pending
- 1997-07-18 AU AU28752/97A patent/AU725496B2/en not_active Ceased
- 1997-07-19 KR KR1019970033826A patent/KR100247672B1/ko not_active Expired - Fee Related
-
1998
- 1998-11-20 US US09/197,070 patent/US5958910A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ZA976222B (en) | 1998-01-19 |
| HRP970393A2 (en) | 1998-04-30 |
| NO973338D0 (no) | 1997-07-18 |
| BR9704023A (pt) | 1998-11-17 |
| HU9701193D0 (en) | 1997-09-29 |
| NZ328331A (en) | 1999-05-28 |
| HUP9701193A3 (en) | 2000-08-28 |
| PL321203A1 (en) | 1998-02-02 |
| KR980008228A (ko) | 1998-04-30 |
| IL121298A0 (en) | 1998-01-04 |
| CO4900053A1 (es) | 2000-03-27 |
| IL121298A (en) | 2001-03-19 |
| MA24273A1 (fr) | 1998-04-01 |
| CA2210613A1 (en) | 1998-01-19 |
| TR199700653A2 (xx) | 1998-02-21 |
| HUP9701193A2 (hu) | 1999-02-01 |
| AU2875297A (en) | 1998-01-29 |
| JPH1067761A (ja) | 1998-03-10 |
| KR100247672B1 (ko) | 2000-04-01 |
| SG91796A1 (en) | 2002-10-15 |
| US5958910A (en) | 1999-09-28 |
| JP2991679B2 (ja) | 1999-12-20 |
| YU30297A (sh) | 2000-10-30 |
| EP0819681A3 (de) | 1998-02-04 |
| EP0819681A2 (de) | 1998-01-21 |
| CN1176101A (zh) | 1998-03-18 |
| CZ227397A3 (cs) | 1998-02-18 |
| PE91298A1 (es) | 1998-12-31 |
| MX9705385A (es) | 1998-04-30 |
| US5877193A (en) | 1999-03-02 |
| AU725496B2 (en) | 2000-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU30297A (sh) | Derivati n-(4-aril-tiazol-2-il)-sulfonamida i njihova primena | |
| AU692090B2 (en) | Novel 4,6-diarylpyrimidine derivatives and salts thereof | |
| MY114679A (en) | Aroyl-piperidine derivatives | |
| AP2002002637A0 (en) | Novel piperazine | |
| AR007898A1 (es) | Un compuesto derivado de la 4-hidroxi-piperidina, su empleo para la elaboracion de un medicamento, un procedimiento para prepararlo, y un medicamento que lo contiene. | |
| NO990433L (no) | Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet | |
| NO986055D0 (no) | Nye heterocykliske forbindelser, deres fremstilling, farmas÷ytiske preparat | |
| WO2000071510A3 (en) | INHIBITORS OF FACTOR Xa | |
| PT1465861E (pt) | Derivados de α-(n-sulfonamido)-acetamida como inibidores β-amilóides | |
| FI941022A0 (fi) | Spirosykliset piperidiinijohdannaiset | |
| WO2000047554A3 (en) | INHIBITORS OF FACTOR Xa | |
| ATE254618T1 (de) | Spiro chinuclidin-derivate, ihre herstellung und verwendung | |
| DE69720709D1 (de) | Substituierte tetracyclische tetrahydrofuranderivate | |
| ECSP930953A (es) | Nuevos derivados de indol | |
| BG100883A (en) | Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors | |
| ATE211740T1 (de) | Substituierte indazolderivate | |
| NO930783D0 (no) | Kondenserte heterocykliske ketonderivater deres fremstilling og anveendelse | |
| ATE148098T1 (de) | Benzolderivate zum fördern der produktion des nervenwachstumsfaktors | |
| DK0526313T3 (da) | Nye ureaderivater, deres fremstilling og terapeutiske anvendelse | |
| EP0949242A4 (en) | AROMATIC AMINE DERIVATIVES WITH NOS-INHIBITING EFFECT | |
| EP1382598A4 (en) | NEW HETEROCYCLIC DERIVATIVES | |
| AU640590B2 (en) | 3-(1h-indazol-3-yl)-4-pyridinamines | |
| DK1178047T3 (da) | Diazabicyclooctanderivater og terapeutiske anvendelser deraf | |
| AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
| NO971424L (no) | Nye heterocyklisk substituerte imidazolo-kinoksalinoner, deres fremstilling og anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |